About

RNAble is a biotechnology startup focused on developing novel compounds that modulate RNA stability through epitranscriptomics. Their approach targets specific cancers and rare genetic diseases caused by nonsense mutations, aiming to restore protein function.

Key facts

At-a-glance profile data

Website: futurx.co.il
Headquarters: Tel Aviv, Israel
Founded: 2021
Employees: 2
Total funding: -
Business model: B2B

Tech stack

Detected on futurx.co.il, last scanned 7 Jun 2026. Run your own scan

Email provider: Microsoft 365

Add first review

Frequently asked

How many employees does RNAble have?

RNAble has approximately 2 people on record.

What is RNAble's current status?

RNAble's current operating status is: Inactive.